Chronic inflammation and CD16+ natural killer cell zeta-chain downregulation in hemodialysis patients

Blood Purif. 2008;26(4):317-21. doi: 10.1159/000130068. Epub 2008 May 8.

Abstract

Background: Natural killer (NK) cell activity is decreased in hemodialysis (HD) patients. Zeta-chain phosphorylation is an early event that follows the triggering of some NK cell-activating receptors. NK cell zeta-chain is downregulated in patients with cancer due to chronic inflammation. HD is also a chronic inflammatory state. NK cell zeta-chain expression in HD was evaluated.

Patients and methods: Thirty-three HD patients and 30 healthy volunteers were enrolled into the study. The CD3-CD16+ subpopulation was examined, since it corresponds to 90% of all NK cells and has the highest cytotoxicity.NK cell count and zeta-chain mean fluorescence intensity were evaluated with flow cytometry. The inflammatory markers C-reactive protein, IL-6 and tumor necrosis factor-alpha were measured with ELISA.

Results: The inflammatory markers were increased in HD patients. NK cell count did not differ between HD patients and healthy volunteers. NK cell zeta-chain mean fluorescence intensity was decreased in the patient group.

Conclusions: Chronic inflammation could be responsible for the NK cell zeta- chain downregulation in HD patients, contributing to the decreased NK cell activity.

MeSH terms

  • Aged
  • Biomarkers / analysis
  • CD3 Complex
  • Case-Control Studies
  • Chronic Disease
  • Down-Regulation
  • Female
  • Flow Cytometry
  • Humans
  • Inflammation / pathology*
  • Kidney Failure, Chronic / pathology*
  • Killer Cells, Natural / pathology*
  • Lymphocyte Count
  • Male
  • Middle Aged
  • Receptors, Antigen, T-Cell / analysis*
  • Receptors, IgG
  • Renal Dialysis

Substances

  • Biomarkers
  • CD3 Complex
  • Receptors, Antigen, T-Cell
  • Receptors, IgG
  • antigen T cell receptor, zeta chain